Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, 03 1996, 151-155, Vol 3, No. 2
L Mercure, GS Tannenbaum, HM Schipper, D Phaneuf and MA Wainberg
Somatostatin (somatotropin release-inhibiting hormone; SRIH) has been
demonstrated in neurons of the central nervous system (CNS) as well as in
endocrine cells of the pancreas and gastrointestinal tract and can suppress
various immune functions including lymphocyte proliferation, immunoglobulin
synthesis, and cytokine production. Since astrocytes possess
antigen-presenting activity and can secrete a wide array of
immunoregulatory and inflammatory cytokines, we studied SRIH gene
expression in both astrocyte cell lines and mitogen-stimulated peripheral
blood mononuclear leukocytes from healthy donors. We now report by means of
a complementary DNA-based reverse transcription PCR that differential
levels of SRIH mRNA were expressed in 9 of 11 human astrocytoma cell lines
tested but were undetectable in activated peripheral blood mononuclear
leukocytes as well as in a variety of human lymphocyte and monocyte cell
lines. The synthesis and secretion of SRIH protein by astrocytoma cells
that expressed SRIH transcripts were confirmed by specific radioimmunoassay
of cell culture fluids. These findings support the notion that SRIH gene
expression occurs in human astrocytoma cells but not in mature lymphoid
cells of the immune system.
Copyright © 1996 by the American Society for Microbiology. All rights reserved.
Expression of the somatostatin gene in human astrocytoma cell lines
McGill University AIDS Centre, Montreal, Quebec, Canada.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |